byiShook Opinion
Dec 3, 2024 - 11:55
Shares of Janux Therapeutics skyrocketed Tuesday on "unprecedented" results for an experimental prostate cancer treatment. The post Janux Catapults 70% On 'Unprecedented' Results In Prostate Cancer; Vir Goes For A Ride appeared first on Investor's Business Daily.
Shares of Janux Therapeutics skyrocketed Tuesday on "unprecedented" results for an experimental prostate cancer treatment.
The post Janux Catapults 70% On 'Unprecedented' Results In Prostate Cancer; Vir Goes For A Ride appeared first on Investor's Business Daily.